Search

Your search keyword '"Fischer, Thea K."' showing total 78 results

Search Constraints

Start Over You searched for: Author "Fischer, Thea K." Remove constraint Author: "Fischer, Thea K." Database Unpaywall Remove constraint Database: Unpaywall
78 results on '"Fischer, Thea K."'

Search Results

1. Immune cell populations and induced immune responses at admission in patients hospitalized with vaccine breakthrough SARS-CoV-2 infections

4. Implementation of Intelligent Physical Exercise Training at a Danish Hospital—A Qualitative Study of Employees’ Barriers and Facilitators for Participation

5. Respiratory Syncytial Virus–Associated Hospitalization in Adults With Comorbidities in 2 European Countries: A Modeling Study

6. Wastewater Surveillance in Europe for Non-Polio Enteroviruses and Beyond

8. SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection

11. New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic

14. High titers of neutralizing SARS-CoV-2 antibodies six months after symptom onset are associated with increased severity in COVID-19 hospitalized patients

15. Hospitalisation at Home of Patients with COVID-19: A Qualitative Study of User Experiences

16. A Cross-Sectional Study of SARS-CoV-2 Antibodies and Risk Factors for Seropositivity in Staff in Day Care Facilities and Preschools in Denmark

17. Persistent Symptoms and Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection Not Requiring Hospitalization: Results From Testing Denmark, a Danish Cross-sectional Survey

18. Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections

19. Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study

20. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study

21. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

22. Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark

23. Levels of SARS-CoV-2 Antibodies Among Fully-Vaccinated Individuals With Delta or Omicron Variant Breakthrough Infections: A Prospective Cohort Study

24. Persistent Symptoms and Sequelae after SARS-CoV-2 Infection Not Requiring Hospitalization: Results from Testing Denmark, a Danish Cross-Sectional Survey

26. Reduced Risk of Hospitalisation Associated With Infection With SARS-CoV-2 Omicron Relative to Delta: A Danish Cohort Study

27. Testing Denmark: a Danish Nationwide Surveillance Study of COVID-19

29. Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021

30. Origins of SARS-CoV-2: window is closing for key scientific studies

31. Testing Denmark: A Danish nationwide surveillance study of COVID-19

32. Mapping of serological testing and SARS-CoV-2 seroprevalence studies performed in 20 European countries, March-June 2020

33. Molecular Epidemiology and Evolutionary Trajectory of Emerging Echovirus 30, Europe

34. Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark

35. Household Exposure to Severe Acute Respiratory Syndrome Coronavirus 2 and Association With Coronavirus Disease 2019 Severity: A Danish Nationwide Cohort Study

36. Recommendations for respiratory syncytial virus surveillance at the national level

37. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study

38. Long-Term Survival, Health, Social Functioning, and Education in Patients With an Enterovirus Central Nervous System Infection, Denmark, 1997–2016

39. Circulation of non-polio enteroviruses in 24 EU and EEA countries between 2015 and 2017: a retrospective surveillance study

43. Erratum to “Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe – Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18” [Vaccine 35 (2017) 4828–4835]

44. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe

45. Cadherin-related Family Member 3 Genetics and Rhinovirus C Respiratory Illnesses

47. Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark

50. Molecular epidemiology and the evolution of human coxsackievirus A6

Catalog

Books, media, physical & digital resources